News
Meet The Team - Rachel Robinson - Lead Clinical Researcher
My name is Rachel Robinson and I joined Neurovalens in September 2022 as a Lead Clinical Researcher. From a young age I was always fascinated about the function and development of the human body and this is the main reason I chose to focus my studies within the fields of anatomy and physiology.
ISO 13485 Certified Medical Device Company
Neurovalens are an ISO 13485 certified medical device company.
This is an international standard that sets out regulatory requirements for medical device quality management systems.
Neurovalens at 10 Downing Street
Our CEO, Jason McKeown was invited back to 10 Downing Street today to discuss our recently FDA cleared treatment for chronic insomnia.
Medica 2023
CPO Iain Hendrick and Software QA Manager Steven George attended Medica 2023 in Düsseldorf, Germany to showcase the newly FDA cleared Modius Sleep headset.
Meet The Team - Steven George - Software QA Manager
I'm Steven George, but most people know me as Stevie. I've been at Neurovalens almost 6 years, it feels like no time since I joined yet so much has changed and so much has been achieved.
Neurovalens receives FDA clearance for medical device to treat insomnia
Neurovalens, a global leader in non-invasive neuro-technology, has received medical device clearance from the US Food & Drug Administration (FDA) to treat chronic insomnia with its Modius Sleep device.
Meet The Team - Erin McCulloch - Clinical Trial Coordinator
My name is Erin, and I am a Clinical Trial Coordinator at Neurovalens. I joined the team in September 2020. I initially joined Neurovalens as a year-long placement student during my Pharmaceutical Biotechnology at Queen’s University Belfast.
Modius Spero - A non-invasive, drug-free technology being trialled as a potential treatment for PTSD
Neurovalens is studying the efficacy of a non-invasive electrical vestibular nerve stimulation (VeNS) device, the Modius Spero device, as a method of treating Post-Traumatic Stress Disorder (PTSD).
Meet The Team - Iain Hendrick - CPO
Iain Hendrick is Chief Project Officer at Neurovalens. He studied Electrical & Electronic Engineering, focused on Control Systems & DSP. Enjoys working at Neurovalens for its impactful technology and great team, hobbies include cycling and playing guitar.
Meet The Team - Chris McCabe - CTO
In this Q&A session with our CTO, Chris McCabe, we delve into his background and journey in the tech industry. He shares how he got into the field and what led him to join Neurovalens. Chris also shares his thoughts on what he enjoys about his work plus much more.
World Diabetes Day
Diabetes is a chronic disease, that causes blood sugar levels in your body to become too high, either due to your body not being able to respond properly to insulin or due to your body not being unable to produce any at all. If left untreated, this can lead to serious complications such as heart attack, stroke, obesity, eye disease, kidney disease and nerve damage.
Make Mental Health a Priority
There are nearly one billion people worldwide who suffer from mental disorders. There is a stigma surrounding mental health making it difficult to speak up and seek help.
Covid 19 has been a huge impact on people's mental health all around the world. Within the first year of Covid-19, there has been a 25% increase in anxiety and depression worldwide.
